4.1 Patient Screening Protocols, Health History Questionnaires, and Immunization Information Systems (IIS)

4.1 Patient Screening Protocols, Health History Questionnaires, and Immunization Information Systems (IIS)

Core Clinical Principle: Pre-vaccination screening is the primary clinical safety gateway in immunization delivery. Every vaccine administration encounter—regardless of setting or patient familiarity—must include systematic screening to identify contraindications and precautions. Review available records and the jurisdictional IIS when authorized and accessible, then follow site procedures for history reconciliation and dose forecasting.

---

1. Standardized CDC Pre-Vaccination Screening Questionnaires

Use a current standardized pre-vaccination screening checklist, such as the Immunize.org checklists linked by CDC for children/teens and adults. These tools systematically ask about health states, prior reactions, and therapies that can affect vaccine safety or effectiveness; always use the current version required by the site.

+---------------------------------------------------------------------------------------------------+
|                       STANDARDIZED PRE-VACCINATION SCREENING CHECKLISTS                             |
|                                                                                                   |
|  1. Screening Questionnaire for Child and Teen Immunization (Birth through 18 Years)              |
|     - Probes acute illness, past vaccine reactions, allergies (food, med, latex), chronic health  |
|       conditions, seizures/brain disorders, immune compromise, biologics/steroids, blood products,|
|       pregnancy status, and recent live vaccinations within the preceding 28 days.               |
|                                                                                                   |
|  2. Screening Questionnaire for Adult Immunization (Ages 19 Years and Older)                      |
|     - Evaluates acute illness, severe allergies (egg, gelatin, latex, PEG, polysorbate, neomycin),|
|       previous vaccine adverse reactions, chronic health conditions (heart, lung, kidney, liver,  |
|       diabetes, asplenia), immunocompromising conditions/medications, history of Guillain-Barré   |
|       Syndrome (GBS), pregnancy/lactation, blood product transfusions, and recent live vaccines.  |
+---------------------------------------------------------------------------------------------------+

Systematic Clinical Rationale Behind Key Screening Questions

1. "Is the patient sick today?"
   • Rationale: Identifies acute moderate or severe illness (with or without fever) requiring temporary deferral to avoid diagnostic confusion between acute disease progression and vaccine reactogenicity.
2. "Does the patient have allergies to medications, food, a vaccine component, or latex?"
   • Rationale: Identifies potential IgE-mediated Type I hypersensitivity triggers (e.g., gelatin, yeast, neomycin, latex packaging stoppers, PEG) that represent absolute contraindications.
3. "Has the patient ever had a serious reaction to a vaccine in the past?"
   • Rationale: Screens for past anaphylaxis, pertussis-associated encephalopathy within 7 days, or other serious adverse events that contraindicate subsequent doses.
4. "Does the patient have a long-term health problem (e.g., heart disease, lung disease, asthma, kidney disease, diabetes, anemia, or asplenia)?"
   • Rationale: Identifies indications for high-risk clinical schedules (e.g., pneumococcal conjugate PCV20, meningococcal MenACWY/MenB, Hepatitis B in diabetes, RSV in chronic cardiopulmonary disease) and flags precautions for live intranasal influenza (LAIV).
5. "Does the patient have cancer, leukemia, HIV/AIDS, or any other immune system problem?"
   • Rationale: Severe altered immunocompetence contraindicates all live attenuated vaccines (MMR, Varicella, LAIV, live oral typhoid, yellow fever) due to the risk of uncontrolled viral replication.
6. "In the past 3 months, has the patient taken medications that weaken the immune system (e.g., oral cortisone/prednisone, chemotherapy, radiation, or biologic response modifiers)?"
   • Rationale: High-dose systemic corticosteroids (>=20 mg/day prednisone equivalent for >=14 days), alkylating agents, antimetabolites, TNF-alpha inhibitors, and anti-CD20 monoclonal antibodies induce severe immunosuppression that contraindicates live vaccines.
7. "Has the patient received a transfusion of blood, blood products, or immune globulin in the past year?"
   • Rationale: Passively acquired antibodies neutralize live attenuated parenteral vaccines (MMR, Varicella), necessitating deferral intervals of 3 to 11 months depending on the blood product dosage.
8. "Is the patient pregnant or is there a chance they could become pregnant in the next month?"
   • Rationale: MMR, varicella, LAIV, and oral Ty21a are contraindicated during pregnancy because of theoretical fetal risk. Yellow fever is a precaution requiring individual risk-benefit assessment. Tdap (weeks 27–36) and inactivated influenza are specifically indicated.
9. "Has the patient received any vaccinations in the past 4 weeks?"
   • Rationale: Live parenteral or intranasal vaccines must be administered on the same calendar day or spaced by at least 28 days (4 weeks) to prevent transient interferon-mediated immune interference.

---

2. Comprehensive Pre-Vaccination Clinical Screening Table

---

3. State Immunization Information Systems (IIS / Registries)

An Immunization Information System (IIS)—commonly referred to as a state immunization registry—is a confidential, secure, population-based computer database that consolidates all vaccine doses administered by participating healthcare providers within a defined geographic region (state, territory, or major metropolitan area).

+---------------------------------------------------------------------------------------------------+
|                          IMMUNIZATION INFORMATION SYSTEM (IIS) WORKFLOW                           |
|                                                                                                   |
|   [ Pharmacy Practice Management System ] <==== HL7 Real-Time Bidirectional Link ====> [ State IIS ]|
|                                                                                                   |
|   Step 1: Patient Check-In  ===>  Electronic Query by Parameter (HL7 QBP-Q11)                     |
|   Step 2: Registry Response ====> Master Record Return (HL7 RSP-K11) with Forecast & History      |
|   Step 3: Clinical Review   ====> Reconcile Discrepancies, Detect Overdue Doses, Rule Out Dupes  |
|   Step 4: Post-Admin Update ====> Unsolicited Vaccination Record Update (HL7 VXU-V04)             |
+---------------------------------------------------------------------------------------------------+

Bidirectional Querying and Data Standards

Pharmacy systems may interface with an IIS using Health Level Seven (HL7) standard messaging, but query capability, supported fields, timing, and participation rules vary by jurisdiction and system:

• QBP (Query by Parameter): An authorized pharmacy system may transmit patient demographic data (full legal name, date of birth, sex, address, phone number) to search for existing registry profiles.
• RSP (Response): A capable IIS may return available vaccination history and clinical decision support (CDS) forecasting that indicates which vaccines are due, overdue, or upcoming.
• VXU (Vaccination Update): Following vaccine administration, an authorized pharmacy system may submit a VXU transaction with the data elements required by the jurisdiction and interface specification.

Key Clinical Functions of IIS in Pharmacy Workflow

1. Verifying Complete Vaccination History: Patients frequently receive vaccines across fragmented settings (pediatrician offices, school clinics, urgent cares, occupational health clinics, travel clinics, and competing retail pharmacies). The IIS creates a unified longitudinal record.
2. Preventing Accidental Duplicate Dosing: Inadvertently repeating a vaccine dose too soon increases reactogenicity (e.g., extensive Arthus-type local swelling from excess tetanus toxoid) and wastes costly biological products.
3. Resolving Conflicting Records: Use written records and available IIS entries when determining prior doses. If records cannot be located, follow ACIP vaccine-specific guidance rather than inventing dates; self-reported influenza and PPSV23 history may be accepted, while most other vaccines generally require documentation.
4. Identifying Missed Opportunities and Gaps: Clinical decision support engines within IIS flag overdue vaccines (e.g., catch-up HPV, MenACWY booster, Shingrix dose 2, pneumococcal conjugate) during routine encounters.

---

4. Patient Interviewing Techniques, Health Literacy, and Communication

Clinical screening requires more than handing a patient a paper form. Pharmacy technicians must conduct a structured, empathetic patient interview to confirm written responses, evaluate non-verbal cues, and ensure clear comprehension.

Identifying Non-Verbal Cues and Physiological Distress

• Pre-Syncope / Needle Phobia Signs: Patients experiencing severe vasovagal anxiety often exhibit pallor (pale skin), diaphoresis (cold sweats), rapid shallow breathing, tremulousness, avoidance of eye contact, or fidgeting.
• Action: Immediately escort the patient to a private, seated or supine injection station with a reclining chair. Never administer vaccines to a patient standing up or sitting on an elevated, unsupported exam table.
• Acute Physical Distress: Audible wheezing, productive cough, lethargy, flushed skin, or visible shivering indicates acute moderate-to-severe illness warranting temperature measurement and pharmacist triage.

Health Literacy Considerations and Plain-Language Translations

Many patients have limited health literacy or unfamiliarity with clinical terminology. Pharmacy technicians must translate complex screening questions into clear, accessible language:

+---------------------------------------------------------------------------------------------------+
|                           HEALTH LITERACY TRANSLATION GUIDE FOR SCREENING                         |
|                                                                                                   |
|   Medical Jargon Term                 Plain-Language Patient Translation                          |
|   ----------------------------------  ---------------------------------------------------------   |
|   "Altered immunocompetence"          "Do you have a weakened immune system from an illness or   |
|                                        medications like chemotherapy or high-dose steroids?"      |
|                                                                                                   |
|   "Anaphylaxis"                       "Have you ever had a life-threatening reaction causing       |
|                                        trouble breathing, throat closing, or needing EpiPen?"     |
|                                                                                                   |
|   "Adverse event"                     "Did you have any serious medical problems after shots?"    |
|                                                                                                   |
|   "Subcutaneous vs. Intramuscular"   "Into the fatty layer under the skin or deep in the muscle" |
|                                                                                                   |
|   "Immunization Information System"   "Your secure state immunization registry record"           |
+---------------------------------------------------------------------------------------------------+

The Teach-Back Method and Vaccine Information Statements (VIS)

• Federal VIS Requirement: Under the National Childhood Vaccine Injury Act (NCVIA), healthcare providers must provide the current official Vaccine Information Statement (VIS) to the patient or legal representative before each dose of a vaccine covered by the Act. Product fact sheets or other handouts do not substitute for a required VIS.
• Language Access: The official English VIS is the controlling document. A translated VIS may be provided to support comprehension when available, while following site language-access policy.
• Teach-Back Verification: Confirm patient comprehension by asking open-ended questions: "To make sure we covered everything clearly, what are the most common mild side effects you should watch for at home?"

---

5. Establishing Eligibility, Identity Verification, and Insurance / VFC Programs

Before preparing and drawing up vaccines, the pharmacy team must complete administrative and regulatory eligibility checks:

1. Identity and Age Verification

• Verify patient identity using the identifiers and documentation required by the site, payer, and jurisdiction; government-issued photo ID is not a universal federal prerequisite for vaccination.
• Calculate exact chronological age. Cross-reference age against FDA licensure indications, ACIP schedule boundaries, and state-specific pharmacist/technician immunization protocol age restrictions (e.g., some states authorize pharmacy administration only for patients aged 3+ or 7+ years).

2. Insurance Billing Pathways

• Commercial Health Plans: Verify current plan and network rules. Most non-grandfathered plans generally cover qualifying ACIP-recommended routine vaccines without cost-sharing in-network, subject to recommendation effective dates and applicable law.
• Medicare Part B: Covers specific vaccines: Annual Influenza, Pneumococcal vaccines, COVID-19 vaccines, and Hepatitis B vaccines (for individuals at intermediate or high risk of hepatitis B infection).
• Medicare Part D: Covers ACIP-recommended adult vaccines that are covered under Part D with no deductible or cost-sharing. Examples can include Shingrix, Tdap, RSV, hepatitis A, and certain recommended travel vaccines; verify the product and plan claim pathway.

3. The Vaccines for Children (VFC) Program

The Vaccines for Children (VFC) program is a federally funded entitlement program established in 1994 that supplies vaccines at no cost to eligible children.

+---------------------------------------------------------------------------------------------------+
|                                   VFC PROGRAM COMPLIANCE RULES                                    |
|                                                                                                   |
|  1. ELIGIBILITY CRITERIA (Children Aged 18 Years and Younger who meet >=1 condition):             |
|     - Medicaid-eligible (enrolled in Medicaid)                                                    |
|     - Uninsured (no health insurance)                                                             |
|     - American Indian or Alaska Native (AI/AN)                                                    |
|     - Underinsured (insurance does not cover vaccines; ONLY eligible at FQHCs or RHCs)            |
|                                                                                                   |
|  2. STRICT STOCK SEGREGATION:                                                                     |
|     - VFC vaccine stock is federally owned and MUST be physically labeled and stored separately    |
|       from private commercial inventory in the pharmacy refrigerator/freezer.                     |
|     - Borrowing vaccine doses between VFC and commercial stocks is strictly restricted and         |
|       requires mandatory state-documented borrowing logs with exact replacement tracking.         |
|                                                                                                   |
|  3. BILLING COMPLIANCE:                                                                           |
|     - The pharmacy CANNOT bill the patient, family, or Medicaid for the cost of the vaccine        |
|       antigen itself.                                                                             |
|     - The pharmacy may only bill an allowable regional administration fee to Medicaid; this fee   |
|       cannot be charged to the family if they cannot afford to pay.                               |
+---------------------------------------------------------------------------------------------------+